Cordyceps militaris compound for improving respiratory diseases

The present invention provides a cordyceps militaris composition for improving respiratory diseases, including 60-95% by weight of Cordyceps militaris, 2-25% by weight of Panax quinquefolius, and 2-25% by weight of Eleutherococcus senticosus. Wherein, a cordycepin accounts for the weight percentage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHAO, SHIHING, TSAI, MING-SHIUN, WANG, SUE-HONG, YU, FU-HUA, YUO, SHIN-HWEI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHAO, SHIHING
TSAI, MING-SHIUN
WANG, SUE-HONG
YU, FU-HUA
YUO, SHIN-HWEI
description The present invention provides a cordyceps militaris composition for improving respiratory diseases, including 60-95% by weight of Cordyceps militaris, 2-25% by weight of Panax quinquefolius, and 2-25% by weight of Eleutherococcus senticosus. Wherein, a cordycepin accounts for the weight percentage of the cordyceps militaris composition between 0.5% and 2.0%. A cordyceps polysaccharide accounts for the weight percentage of the cordyceps militaris composition between 2.0% and 9.0%. An adenosine accounts for the weight percentage of the cordyceps militaris composition between 0.02% and 0.4%. The cordyceps militaris composition is used to make a health food or a medicament. The present invention relieves the inflammatory symptoms of the respiratory tract by inhibiting the contents of the inflammatory cytokines IL-1[beta] and TNF-[alpha] and reducing the aggregation of leukocyte. In addition, the cordyceps militaris composition has better anti-inflammation capability than the single cordyceps militaris.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202000217A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202000217A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202000217A3</originalsourceid><addsrcrecordid>eNrjZLB3zi9KqUxOLShWyM3MySxJLMosVkjOzy3IL81LUUjLL1LIzC0oyi_LzEtXKEotLsgsSizJL6pUSMksTk0sTi3mYWBNS8wpTuWF0twMim6uIc4euqkF-fFA9YnJqXmpJfEh4UYGRgYGBkaG5o7GxKgBABBeMgw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cordyceps militaris compound for improving respiratory diseases</title><source>esp@cenet</source><creator>CHAO, SHIHING ; TSAI, MING-SHIUN ; WANG, SUE-HONG ; YU, FU-HUA ; YUO, SHIN-HWEI</creator><creatorcontrib>CHAO, SHIHING ; TSAI, MING-SHIUN ; WANG, SUE-HONG ; YU, FU-HUA ; YUO, SHIN-HWEI</creatorcontrib><description>The present invention provides a cordyceps militaris composition for improving respiratory diseases, including 60-95% by weight of Cordyceps militaris, 2-25% by weight of Panax quinquefolius, and 2-25% by weight of Eleutherococcus senticosus. Wherein, a cordycepin accounts for the weight percentage of the cordyceps militaris composition between 0.5% and 2.0%. A cordyceps polysaccharide accounts for the weight percentage of the cordyceps militaris composition between 2.0% and 9.0%. An adenosine accounts for the weight percentage of the cordyceps militaris composition between 0.02% and 0.4%. The cordyceps militaris composition is used to make a health food or a medicament. The present invention relieves the inflammatory symptoms of the respiratory tract by inhibiting the contents of the inflammatory cytokines IL-1[beta] and TNF-[alpha] and reducing the aggregation of leukocyte. In addition, the cordyceps militaris composition has better anti-inflammation capability than the single cordyceps militaris.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202000217A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202000217A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAO, SHIHING</creatorcontrib><creatorcontrib>TSAI, MING-SHIUN</creatorcontrib><creatorcontrib>WANG, SUE-HONG</creatorcontrib><creatorcontrib>YU, FU-HUA</creatorcontrib><creatorcontrib>YUO, SHIN-HWEI</creatorcontrib><title>Cordyceps militaris compound for improving respiratory diseases</title><description>The present invention provides a cordyceps militaris composition for improving respiratory diseases, including 60-95% by weight of Cordyceps militaris, 2-25% by weight of Panax quinquefolius, and 2-25% by weight of Eleutherococcus senticosus. Wherein, a cordycepin accounts for the weight percentage of the cordyceps militaris composition between 0.5% and 2.0%. A cordyceps polysaccharide accounts for the weight percentage of the cordyceps militaris composition between 2.0% and 9.0%. An adenosine accounts for the weight percentage of the cordyceps militaris composition between 0.02% and 0.4%. The cordyceps militaris composition is used to make a health food or a medicament. The present invention relieves the inflammatory symptoms of the respiratory tract by inhibiting the contents of the inflammatory cytokines IL-1[beta] and TNF-[alpha] and reducing the aggregation of leukocyte. In addition, the cordyceps militaris composition has better anti-inflammation capability than the single cordyceps militaris.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB3zi9KqUxOLShWyM3MySxJLMosVkjOzy3IL81LUUjLL1LIzC0oyi_LzEtXKEotLsgsSizJL6pUSMksTk0sTi3mYWBNS8wpTuWF0twMim6uIc4euqkF-fFA9YnJqXmpJfEh4UYGRgYGBkaG5o7GxKgBABBeMgw</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>CHAO, SHIHING</creator><creator>TSAI, MING-SHIUN</creator><creator>WANG, SUE-HONG</creator><creator>YU, FU-HUA</creator><creator>YUO, SHIN-HWEI</creator><scope>EVB</scope></search><sort><creationdate>20200101</creationdate><title>Cordyceps militaris compound for improving respiratory diseases</title><author>CHAO, SHIHING ; TSAI, MING-SHIUN ; WANG, SUE-HONG ; YU, FU-HUA ; YUO, SHIN-HWEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202000217A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHAO, SHIHING</creatorcontrib><creatorcontrib>TSAI, MING-SHIUN</creatorcontrib><creatorcontrib>WANG, SUE-HONG</creatorcontrib><creatorcontrib>YU, FU-HUA</creatorcontrib><creatorcontrib>YUO, SHIN-HWEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAO, SHIHING</au><au>TSAI, MING-SHIUN</au><au>WANG, SUE-HONG</au><au>YU, FU-HUA</au><au>YUO, SHIN-HWEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cordyceps militaris compound for improving respiratory diseases</title><date>2020-01-01</date><risdate>2020</risdate><abstract>The present invention provides a cordyceps militaris composition for improving respiratory diseases, including 60-95% by weight of Cordyceps militaris, 2-25% by weight of Panax quinquefolius, and 2-25% by weight of Eleutherococcus senticosus. Wherein, a cordycepin accounts for the weight percentage of the cordyceps militaris composition between 0.5% and 2.0%. A cordyceps polysaccharide accounts for the weight percentage of the cordyceps militaris composition between 2.0% and 9.0%. An adenosine accounts for the weight percentage of the cordyceps militaris composition between 0.02% and 0.4%. The cordyceps militaris composition is used to make a health food or a medicament. The present invention relieves the inflammatory symptoms of the respiratory tract by inhibiting the contents of the inflammatory cytokines IL-1[beta] and TNF-[alpha] and reducing the aggregation of leukocyte. In addition, the cordyceps militaris composition has better anti-inflammation capability than the single cordyceps militaris.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW202000217A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Cordyceps militaris compound for improving respiratory diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T05%3A57%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHAO,%20SHIHING&rft.date=2020-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202000217A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true